Abivax S.A. Stock
Your prediction
Abivax S.A. Stock
Abivax S.A. gained 0.680% compared to yesterday.
Our community identified positive and negative aspects for Abivax S.A. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abivax S.A. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of Abivax S.A. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abivax S.A. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Abivax S.A. | 0.680% | - | - | - | - | - | - |
Valneva SE | 0.800% | -2.718% | -4.127% | -18.057% | -26.442% | -69.549% | 3.787% |
Nanobiotix | 0.280% | 4.106% | -4.570% | 157.869% | -17.056% | -59.902% | -53.534% |
Transgene S.A. | 1.430% | -10.526% | 15.625% | -29.799% | -6.119% | -49.376% | -56.471% |
Comments
DERFY stimmt der Outperform-Einschätzung der institutionellen Analysten zu
DERFY stimmt am 12.07.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 26.97€ zu.News
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax reports 2023 financial results and operational update
EQS-News: Abivax reports 2023 financial results and operational update
EQS-News: Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
EQS-News: Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)